Rolapitant
Substance P/Neurokinin-1 Receptor Antagonist
Brands
Rolapitant Injection
| Dosage | Brand | Image |
|---|---|---|
| 92.5 ML rolapitant 1.8 MG/ML Injection | Generic | |
| 92.5 ML rolapitant 1.8 MG/ML Injection [Varubi] | Generic |
Rolapitant Oral Tablet
| Dosage | Brand | Image |
|---|---|---|
| rolapitant 90 MG Oral Tablet | Generic | |
| rolapitant 90 MG Oral Tablet [Varubi] | Generic |
Rolapitant desired effects:
- Decreased Brain Stem Substance P Activity
- Emesis Suppression
- Decreased Kinin Activity
Rolapitant drug classes:
- Substance P/Neurokinin-1 Receptor Antagonist
Rolapitant pharmacologic actions:
- Neurokinin-1 Receptor Antagonists
Rolapitant mechanism of action:
- Cytochrome P450 2D6 Inhibitors
- P-Glycoprotein Inhibitors
- Neurokinin 1 Antagonists
- Breast Cancer Resistance Protein Inhibitors
